ABSTRACT Vascular endothelial cells derived from adult bovine aorta (ABAE) treated with factor Xa and calcium were found to activate prothrombin. In contrast, nonvascular cells (human foreskin fibroblasts, bovine corneal endothelial cells, or human fetal lung cells) had either no or very little effect on prothrombin activation. In the presence of 6 x 105 ABAE cells, 20 ng of factor Xa converted 90 ,.g of prothrombin into 80 units of thrombin after 45 min at 37C. Exogenous factor V was not required for prothrombin activation, but thrombin generation was enhanced 2-to 4-fold by the addition of factor V (500-2,500 ng/ml). Treatment of ABAE cells with anti-bovine factor V IgG markedly inhibited prothrombin activation by factor Xa and calcium. In cells grown in serum-free medium for 3 months, the amount of factor V activity was equivalent to that found in cells grown with serum, which suggests that these cells probably synthesize factor V. Sparse ABAE cells increased prothrombin activation by factor Xa 6-fold compared to activation in confluent cells. Although previous thrombin treatment of ABAE cells did not enhance prothrombin activation, addition of dansyl arginine-4-ethyl piperidine amide markedly inhibited activation of 125I-labeled prothrombin by factor Xa, indicating that thrombin formation is necessary for optimal prothrombin activation. These data indicate that aortic endothelium may provide a physiologically important surface for activation of prothrombin as well as a mechanism for optimal formation of clots at sites of vascular injury.
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In an unperturbed state, vascular tissue is generally considered to be inert with regard to activation of blood clotting (1) . Consistent with this hypothesis, we have found that intact cultured vascular endothelial and smooth muscle cells fail to support initiation of coagulation by either the extrinsic or intrinsic pathways of clotting (2) . In contrast, nonvascular cells initiate activation of the extrinsic pathway by providing tissue factor on their surface (2) . To determine the effects of vascular cells on the final step of activation of the coagulation cascade, conversion of prothrombin to thrombin, we have studied this reaction in the presence of vascular and nonvascular cells in tissue culture. We observed that intact bovine aortic as well as bovine and human umbilical venous endothelial cells, but not nonvascular cells, markedly enhanced prothrombin activation by factor Xa. Furthermore, addition of factor V is not required for this effect, as these vascular cells express factor V activity on their surface. (2, 4, 5) . In separate experiments, ABAE cells were grown in serum-free medium (6, 7) . In these studies, ABAE cells were grown without serum for two passages over a period of 3 months. In experiments in which disrupted cells were assayed, confluent ABAE cells were mechanically homogenized.
MATERIALS AND METHODS
Coagulation Proteins. All coagulation proteins used in these studies were purified from human plasma. Prothrombin and factor X were purified as described (8) and had specific activities of 34 units/mg and 160 units/mg, respectively. Factor V was provided by Joseph P. Miletich (Washington University, St. Louis, MO) and had a specific activity of 170 units/mg (9) . Factor X was activated by RVV immobilized to Sepharose (10) ; the factor X-activating system consisted of factor X (0.03 ml of 2 mg/ml solution), washed RVV beads (0.03 ml), cephalint (0.015 ml of stock solution), and 100 mM CaCl2 (0.01 ml). This mixture was incubated at 37°C for 1 hr with frequent mixing. After centrifugation to sediment'the beads, the supernatant was assayed for factor Xa as described (11) . In a clotting assay (11) , factor Xa at 1 ng/ml yielded a clotting time of 38 sec. Factor V activity was measured using the method of Lewis and Ware (12) . Protein was assayed by the method of Bradford (13) .
Prothrombinase Assay. Cultured adherent cells in 35-mm Petri dishes were washed twice with a buffer of 20 mM Tris.HCl/ 130 mM NaCl/bovine serum albumin (5 mg/ml). Then, 0.8 ml of this buffer was added to the cells, followed by addition of 0.1 ml of 100 mM CaCl2, prothrombin (90 ,g), and factor Xa (20 ng The publication costs of this article were defrayed in part by page charge payment. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. §1734 solely to indicate this fact.
ing. At 200-sec intervals, aliquots of 0.06 ml were removed for assay of thrombin activity by clotting assay (14) . In separate experiments, platelet prothrombinase activity was compared to ABAE cell prothrombinase activity. First, gel-filtered platelets were thrombin-activated (2 units/ml, 5 min at 37C); then, prothrombinase activity was determined as for ABAE cells.
Clotting times were converted to thrombin concentrations (units/ ml) based on a standard curve constructed using purified human a-thrombin (supplied by John W. Fenton II, New York State Department of Health, Albany, NY). The effect of exogenous factor V (50-2,500 ng/ml) on ABAE cell activation of prothrombin was also evaluated. The ability of an antibody to factor V to inhibit endothelial cell prothrombinase activity was studied using a burro anti-bovine factor V IgG (supplied by Kenneth G. Mann and Paula B. Tracy, Mayo Clinic, Rochester, MN). Four micrograms of this anti-factor V IgG precipitates 10 ng of bovine factor V (15). In these experiments, various concentrations of either anti-factor V IgG or a control IgG (goat anti-rabbit) were added to washed cell monolayers 20 min prior to assay of prothrombinase activity.
Role of Thrombin in ABAE Cell Prothrombinase Activity. To determine the effect of the specific thrombin inhibitor dansyl arginine4-ethylpiperidine amide (DAPA) on-activation of prothrombin, 100 ILM DAPA was added to washed ABAE cells prior to the addition of factor Xa (20 ng) and 125I-labeled prothrombin (50 pg). This amount of DAPA inhibited >80 units of thrombin per ml in a clotting assay. Prothrombin was labeled with the lactoperoxidase technique using 20 mM Tris.HCI/150 mM NaCl buffer (16) . Activation of prothrombin was quantitated by NaDodSO4/polyacrylamide gel electrophoresis and autoradiography (16) .
In other experiments, purified thrombin (1-4 units/ml) was incubated with washed ABAE cells for 5-15 min prior to addition of factor Xa and prothrombin. The effects of thrombin pretreatment on prothrombin activation was then determined by clotting assay.
RESULTS
Activation of Prothrombin by Factor Xa and Vascular or Nonvascular Cells. Fig. 1 depicts prothrombin activation by factor Xa in the presence of confluent vascular or nonvascular cells as well as an albumin-coated Petri dish. In these experiments, reactants included cells, factor Xa, prothrombin, and calcium. Only ABAE cells generated significant amounts of thrombin over the incubation period of 20 min (10-15 units/ ml). Of the nonvascular cells studied (bovine corneal endothelial cells, fibroblasts, and fetal lung cells), only the fetal lung cells generated detectable thrombin (:0.8 units/ml). Cell density in these experiments was as follows: ABAE cells, 6 X 105/ ml; fibroblasts, 2.5 x 105/ml; fetal lung cells, 3 X 105/ml; and bovine corneal endothelial cells, 6 x 105/ml. No detectable thrombin activity was observed in the albumin-coated Petri dish. Minimal requirements for activation of prothrombin in this system included endothelial cells, calcium, and factor Xa; if any of these reactants was omitted, no thrombin activity was detected. If factor X was omitted from the RW bead activating system and the supernatant added to the prothrombin assay, no detectable thrombin was generated during a 30-min incubation period, which suggests that a component of RW was not responsible for this effect. When incubations with ABAE cells were continued for 45 min, 80 units of thrombin per ml was generated. In experiments in which ABAE cells were serially passaged in serum-containing medium, there was a progressive loss of procoagulant activity with passage number, such that (Fig. 2) . Generation of thrombin was linear between factor Xa concentrations of Xa >100 ng/ml, a 10-20% inhibition of prothrombin activation was observed. Inhibition of ABAE Cell Prothrombinase Activity by AntiFactor V IgG. Because addition of factor V was not necessary for prothrombin activation by factor Xa and ABAE cells, we next determined whether the ABAE cells provided factor V in this reaction. Disrupted ABAE cells had 0.20-0.30 units of factor V activity per z6 x 105 cells. ABAE cell factor V activity could be inhibited by an anti-factor V IgG (50 pug completely inhibited the factor V activity of =6 x 105 cells). Nonvascular cells and vascular cell lines that had no prothrombinase activity had much less factor V activity (<0.10 unit). When control IgG or burro anti-bovine factor V IgG was incubated with intact washed ABAE cells, there was a concentration-dependent inhibition of prothrombin activation in those cells previously treated with anti-factor V IgG but not with control IgG (Fig. 3) . When antifactor V IgG-containing buffer (100 Ag/ml) was removed and the cells were washed prior to assay of prothrombinase activity, no thrombin generation was detected.
The addition of factor V (50-125 ng/ml) did not enhance prothrombin activation by ABAE cells. However, factor V at 500-2,500 ng/ml accelerated thrombin generation 2-to 4-fold (data not shown).
Fractionation of ABAE Cell Prothrombinase Activity. To determine whether the procoagulant activity of ABAE cells was soluble or associated with the particulate fraction, confluent cells were disrupted by mechanical homogenization and centrifuged at 100,000 x g for 1 hr, the supernatant was removed, and the pellet was resuspended in 0.8 ml of incubation buffer. Both fractions were then assayed for prothrombinase activity as described above. Three-fourths of the total procoagulant activity was present in the 100,000 X g pellet. When factor V activity was assayed in fractionated cells, a similar percentage of cellular factor V activity was found in the 100,000 X g pellet.
In other experiments, prothrombinase activity was assayed in cells passaged twice and grown in serum-free medium for 3 months. At the time of assay of prothrombin activation, passage 12 had been achieved. The amount of thrombin generated in the presence of cells grown in serum-free medium was equivalent to the amount found in identically passaged cells grown in serum-containing medium. After 20 min of incubation with factor Xa (20 ng) and prothrombin (90 pug), 3 .1 units of thrombin per ml was generated in dishes containing cells grown in serumcontaining medium, while 2.9 units of thrombin per ml was generated by cells grown in serum-free medium.
Effect of Thrombin on ABAE Cell Prothrombinase Activity. To determine whether thrombin activates ABAE cell factor V, cells were either previously treated with 1.5-4.0 units of 6 Control IgG 7E To determine the effect of thrombin formation on prothrombin activation, DAPA, an inhibitor of thrombin but not of factor Xa, was added to the incubation mixture. Marked inhibition (-77%) of prothrombin activation was observed (Fig. 4) Fig. 1 . The ABAE cell number was -6 x 10 per ml; thrombin-activated platelets were tested at 6 x 105 per ml to 6 x 107 per ml. Each value represents the mean of duplicate determinations. U, units.
The turnover number for 6 X 107 platelets was 1,114 and compares favorably with the 1,667 obtained previously for 1 x 108 platelets (11) . When dose-response curves with factor Xa and thrombin-activated platelets or ABAE cells were obtained at 6 X 105cells per ml, thrombin generation was detected with both platelets and ABAE cells at factor Xa concentrations as low as 1.5-3.0 ng/ml. At factor Xa concentrations >3 ng/ml, ABAE cells generated 1.5-to 3-fold more thrombin than did an equivalent number of thrombin-activated platelets (data not shown).
DISCUSSION
In previous studies we found that cultured vascular cells do not participate in the initiation of coagulation, which implies that they might be inert with respect-to procoagulant activity (2) (17) . Presumably, factor V is-present on the endothelial cell surface and, after small amounts of prothrombin are converted to thrombin, the factor V is activated, enabling maximal prothrombin activation to-proceed. Our observations also suggest that thrombin is formed-on the cell surface in such a way that it is accessible to cellular factor V.
Platelets also contain factor V (18); however, because platelet factor V is located within the-intracellular. a-granules (19) In addition, there are similarities between species; for example, umbilical vein cells from bovine or human sources have similar activities. Based on these findings, we speculate that prothrombinase activity is maximal in arterial cells. It might be important for arteries to possess this activity because rapid control of hemorrhage is critical for larger vessels. Arterial endothelium may serve as both an amplification and an alternative mechanism for prothrombin activation. Ultimate proof of this hypothesis must await the testing of cultured arterial cells from other species.
The finding that ABAE cells generate more thrombin than do equivalent numbers of thrombin-activated platelets (Fig. 6) indicates that vascular endothelium may also be important for physiological hemostasis. It must be recognized, however, that 6 X 105 cells have =75-fold greater surface area than do an equivalent number of platelets (24) . The observation that sparse ABAE cells generate more thrombin than do confluent cells (Fig. 5) indicates that the rapidly dividing endothelium of an injured vessel wall may contribute to coagulation by mechanisms not previously appreciated.
